The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia

Yunlong Huang, N. Erdmann, J. Zhao, Jialin C Zheng

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

HIV-1 Associated Dementia (HAD) develops during progressive HIV-1 infection and is characterized by cognitive impairments, behavioral disorders and potential progressive motor abnormality. Abnormal inflammation within the central nervous system (CNS), activation of macrophage/microglia and involvement of proinflammatory cytokines have been suggested as primary factors in the pathogenesis of HAD. Impairment of neuronal function and neuronal cell death are believed to be the end pathophysiological result of HAD. TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family of cytokines, was suggested to participate in apoptotic cell death during HAD. As a death ligand, TRAIL was originally thought to target only tumor cells. TRAIL is not typically present in CNS; however, emerging data show that TRAIL can be induced by immune stimuli on macrophage and microglia, major disease effector cells during HAD. Upregulated TRAIL may then cause neuronal apoptosis through direct interaction with TRAIL receptors on neurons or through macrophage death-mediated release of neurotoxins. In this review, we summarize the pivotal role of TRAIL in HAD and TRAIL-initiated intracellular death cascades that culminate in neuronal apoptosis as observed in HAD.

Original languageEnglish (US)
Pages (from-to)135-148
Number of pages14
JournalNeurotoxicity Research
Volume8
Issue number1-2
DOIs
StatePublished - Dec 1 2005

Fingerprint

TNF-Related Apoptosis-Inducing Ligand
Dementia
HIV-1
Macrophages
Neurology
Cell death
Microglia
Cell Death
TNF-Related Apoptosis-Inducing Ligand Receptors
Apoptosis
Cytokines
Central Nervous System
Neurotoxins
Macrophage Activation
Neurons
Tumors
HIV Infections
Chemical activation
Ligands
Cells

Keywords

  • Apoptosis
  • HIV-1 associated dementia
  • Macrophage
  • Neurons
  • TRAIL

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia. / Huang, Yunlong; Erdmann, N.; Zhao, J.; Zheng, Jialin C.

In: Neurotoxicity Research, Vol. 8, No. 1-2, 01.12.2005, p. 135-148.

Research output: Contribution to journalReview article

@article{98aa610f5cfd4c1a8a64d8276c7f3dff,
title = "The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia",
abstract = "HIV-1 Associated Dementia (HAD) develops during progressive HIV-1 infection and is characterized by cognitive impairments, behavioral disorders and potential progressive motor abnormality. Abnormal inflammation within the central nervous system (CNS), activation of macrophage/microglia and involvement of proinflammatory cytokines have been suggested as primary factors in the pathogenesis of HAD. Impairment of neuronal function and neuronal cell death are believed to be the end pathophysiological result of HAD. TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family of cytokines, was suggested to participate in apoptotic cell death during HAD. As a death ligand, TRAIL was originally thought to target only tumor cells. TRAIL is not typically present in CNS; however, emerging data show that TRAIL can be induced by immune stimuli on macrophage and microglia, major disease effector cells during HAD. Upregulated TRAIL may then cause neuronal apoptosis through direct interaction with TRAIL receptors on neurons or through macrophage death-mediated release of neurotoxins. In this review, we summarize the pivotal role of TRAIL in HAD and TRAIL-initiated intracellular death cascades that culminate in neuronal apoptosis as observed in HAD.",
keywords = "Apoptosis, HIV-1 associated dementia, Macrophage, Neurons, TRAIL",
author = "Yunlong Huang and N. Erdmann and J. Zhao and Zheng, {Jialin C}",
year = "2005",
month = "12",
day = "1",
doi = "10.1007/BF03033825",
language = "English (US)",
volume = "8",
pages = "135--148",
journal = "Neurotoxicity Research",
issn = "1029-8428",
publisher = "Springer New York",
number = "1-2",

}

TY - JOUR

T1 - The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia

AU - Huang, Yunlong

AU - Erdmann, N.

AU - Zhao, J.

AU - Zheng, Jialin C

PY - 2005/12/1

Y1 - 2005/12/1

N2 - HIV-1 Associated Dementia (HAD) develops during progressive HIV-1 infection and is characterized by cognitive impairments, behavioral disorders and potential progressive motor abnormality. Abnormal inflammation within the central nervous system (CNS), activation of macrophage/microglia and involvement of proinflammatory cytokines have been suggested as primary factors in the pathogenesis of HAD. Impairment of neuronal function and neuronal cell death are believed to be the end pathophysiological result of HAD. TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family of cytokines, was suggested to participate in apoptotic cell death during HAD. As a death ligand, TRAIL was originally thought to target only tumor cells. TRAIL is not typically present in CNS; however, emerging data show that TRAIL can be induced by immune stimuli on macrophage and microglia, major disease effector cells during HAD. Upregulated TRAIL may then cause neuronal apoptosis through direct interaction with TRAIL receptors on neurons or through macrophage death-mediated release of neurotoxins. In this review, we summarize the pivotal role of TRAIL in HAD and TRAIL-initiated intracellular death cascades that culminate in neuronal apoptosis as observed in HAD.

AB - HIV-1 Associated Dementia (HAD) develops during progressive HIV-1 infection and is characterized by cognitive impairments, behavioral disorders and potential progressive motor abnormality. Abnormal inflammation within the central nervous system (CNS), activation of macrophage/microglia and involvement of proinflammatory cytokines have been suggested as primary factors in the pathogenesis of HAD. Impairment of neuronal function and neuronal cell death are believed to be the end pathophysiological result of HAD. TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family of cytokines, was suggested to participate in apoptotic cell death during HAD. As a death ligand, TRAIL was originally thought to target only tumor cells. TRAIL is not typically present in CNS; however, emerging data show that TRAIL can be induced by immune stimuli on macrophage and microglia, major disease effector cells during HAD. Upregulated TRAIL may then cause neuronal apoptosis through direct interaction with TRAIL receptors on neurons or through macrophage death-mediated release of neurotoxins. In this review, we summarize the pivotal role of TRAIL in HAD and TRAIL-initiated intracellular death cascades that culminate in neuronal apoptosis as observed in HAD.

KW - Apoptosis

KW - HIV-1 associated dementia

KW - Macrophage

KW - Neurons

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=33644839235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644839235&partnerID=8YFLogxK

U2 - 10.1007/BF03033825

DO - 10.1007/BF03033825

M3 - Review article

VL - 8

SP - 135

EP - 148

JO - Neurotoxicity Research

JF - Neurotoxicity Research

SN - 1029-8428

IS - 1-2

ER -